NCT01453361View on ClinicalTrials.gov

Phase II FANG™ in Advanced Melanoma

PHASE2TerminatedINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

March 22, 2016

Study Completion Date

March 22, 2016

Conditions

Advanced Melanoma

Interventions

BIOLOGICAL

Vigil™ Vaccine

Trial Locations (1)

75230

Mary Crowley Cancer Research Centers, Dallas

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Gradalis, Inc.

INDUSTRY